Cure My Disease

Don't miss your cure!

 Log in / Sign up

Florida cancer patients get AI-Powered personalized treatment plans in new study

NCT ID NCT07167381

Recruiting now Knowledge-focused Sponsor: First Ascent Biomedical Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a new tool called xDRIVE, which combines artificial intelligence and tumor profiling, can quickly suggest personalized treatment options for cancer patients in Florida whose cancer has come back or not responded to standard treatments. The goal is to see if the tool can return useful recommendations within two weeks for at least 72% of the 210 participants, including children and underserved communities. If it works, this approach could help doctors make more informed treatment decisions for hard-to-treat cancers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
xDRIVE tumor profiling (diagnostic test using AI and drug sensitivity testing)
What this could lead to
If successful, this could show that AI-driven personalized treatment recommendations are feasible and help doctors choose better therapies for hard-to-treat cancers.
What could go wrong
This is an early feasibility study, not a treatment trial. It may not improve outcomes for all patients, and results depend on timely data return and physician use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer childhood leukemia leukemia lymphoma neoplasm Recurrence refractory malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER LEUKAEMIA LYMPHOMA NEOPLAMS RECURRENCE REFRACTORY SOLID CANCERS SOLID TUMOR MALIGNANCIES

Contacts and locations

Locations

  • First Ascent Biomedical

    RECRUITING

    Miami, Florida, 33183, United States

  • Florida International University

    ACTIVE_NOT_RECRUITING

    Miami, Florida, 33199, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.